Maximum Dose Reached: Exhausted Treatment as Severity Evidence in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a plaintiff's medication reaches the FDA-approved maximum dose, it means the prescriber has exhausted the dosing range for that drug. This clinical ceiling documents that the injury is severe enough to require the most aggressive dose available -- powerful evidence for demand packages.

When a plaintiff's medication has been titrated to the maximum FDA-approved dose, it means the prescriber has reached the clinical ceiling for that drug -- there is no higher dose that can be safely prescribed. Reaching maximum dose is objective, pharmacological evidence that the plaintiff's condition is severe enough to require the most aggressive dosing available for that medication, and it often signals that the current treatment may be insufficient and additional medications or interventions will be needed.

• Reaching maximum dose means the prescriber has exhausted the entire dosing range, documenting that lower doses were insufficient for the plaintiff's condition
• Each dose increase along the way represents a documented clinical decision that the current dose was inadequate
• LienScripts tracks all dose changes through its platform, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting the titration history from initial dose to maximum
• Maximum dose is a clinical fact tied to FDA labeling -- it is not a matter of opinion and cannot be challenged by defense
• Plaintiffs at maximum dose often require additional medications (polypharmacy), further documenting treatment complexity

What Maximum Dose Means Clinically

Every medication has an FDA-approved dosing range. The maximum dose represents the highest amount that has been studied in clinical trials and determined to provide therapeutic benefit without unacceptable risk. When a prescriber titrates a medication to its maximum dose, they have systematically determined that every lower dose was clinically insufficient.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Reaching maximum dose is not a prescriber being aggressive -- it is a prescriber being thorough. They started at the lowest effective dose, gave it time to work, determined it was insufficient, increased the dose, reassessed, and repeated until they hit the FDA ceiling. Every step in that titration is a documented clinical assessment that the plaintiff needed more. When I see gabapentin at 3600mg/day -- the maximum -- I know the prescriber went through 300mg, 600mg, 900mg, 1200mg, 1800mg, 2400mg, and beyond. Each increase is a data point proving the plaintiff's pain required more."

Common Maximum Doses in PI Medications

Several medications commonly prescribed in personal injury cases have well-defined maximum doses:

• Gabapentin: Maximum 3600mg/day (often reached in severe neuropathic pain)
• Pregabalin: Maximum 600mg/day
• Cyclobenzaprine: Maximum 30mg/day (10mg TID)
• Meloxicam: Maximum 15mg/day
• Duloxetine: Maximum 120mg/day for pain management
• Tizanidine: Maximum 36mg/day

When pharmacy records show a plaintiff at any of these maximum doses, the clinical message is clear: the prescriber has used the full therapeutic range and the condition still requires maximum pharmacological intervention.

The Titration Timeline as Evidence

The journey from starting dose to maximum dose creates a compelling evidentiary timeline:

1. Initial dose -- the lowest dose prescribed, typically at the first appointment, with the first fill date
2. First increase -- documentation that the starting dose was insufficient
3. Subsequent increases -- each step up documenting continued insufficiency
4. Maximum dose reached -- the prescriber has exhausted the dosing range
5. Continuation at maximum -- the plaintiff remains at maximum dose, confirming ongoing severe symptoms

This timeline, documented in pharmacy fill records, shows a progressive clinical narrative of injury severity that defense counsel cannot rebut with subjective arguments. Each dose increase is a prescriber's clinical judgment, captured in a pharmacy system with date stamps.

The MERIT report from LienScripts presents this titration history in a clear chronological format with clinical commentary explaining the significance of each dose change.

Maximum Dose and the Need for Polypharmacy

Reaching maximum dose on one medication frequently triggers the addition of another medication from a different class -- what pharmacists call adjuvant therapy. When gabapentin reaches 3600mg/day and the plaintiff still has uncontrolled neuropathic pain, the prescriber may add pregabalin, duloxetine, or a tricyclic antidepressant rather than exceeding the gabapentin maximum.

This transition from maximum monotherapy to polypharmacy is critical evidence of treatment complexity. The plaintiff's condition is so severe that the maximum dose of a single medication is insufficient, requiring additional pharmacological interventions. This directly supports arguments about polypharmacy burden as a damages element.

Using Maximum Dose Evidence in Demand Packages

Include dose titration analysis in every demand package where a plaintiff has reached maximum dose:

1. Starting dose and date -- the initial prescription with its fill date
2. Each dose increase -- listed with dates and the clinical significance of each change
3. Maximum dose reached -- clearly stated with reference to the FDA-approved ceiling
4. Duration at maximum -- how long the plaintiff has remained at maximum dose
5. Additional medications added -- any adjuvant therapies started because maximum monotherapy was insufficient

Countering Defense Arguments

"The prescriber is overprescribing."

Maximum dose is defined by the FDA based on clinical trial data. A prescriber who titrates to maximum dose is practicing within the approved range -- not exceeding it. If the defense argues overprescribing, the response is straightforward: the dose is within the FDA-approved maximum, and the prescriber determined it was clinically necessary based on the plaintiff's documented symptoms.

"The plaintiff does not need that much medication."

The titration history documents that the plaintiff needed exactly that much medication. Lower doses were tried first -- as pharmacy records confirm -- and each was insufficient. The maximum dose is the result of a systematic clinical process, not an arbitrary decision.

Practical Takeaways

Maximum dose is a pharmacological fact with powerful evidentiary implications. When a plaintiff's medication has been titrated to the FDA-approved ceiling, it objectively documents that the prescriber exhausted the full dosing range because the plaintiff's condition demanded maximum pharmacological intervention. Attorneys who present dose titration timelines from LienScripts pharmacy records transform a prescription label into a severity narrative.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes complete titration histories with clinical context.

Related Resources

• Dose Escalation Documents Injury Progression -- How dosage increases prove worsening condition
• Polypharmacy Burden as a Damages Element -- When maximum dose triggers multi-drug regimens
• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary